Evidence map›Paper›PMID 38029085›Full record

ArticleFrontiers in microbiology2023

Comparative diet-gut microbiome analysis in Crohn's disease and Hidradenitis suppurativa.

Peter Cronin, Siobhan McCarthy, Cian Hurley, Tarini Shankar Ghosh, Jakki C Cooney, Ann-Marie Tobin, Michelle Murphy, Eibhlís M O'Connor, Fergus Shanahan, Paul W O'Toole

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Peter CroninDepartment of Biological Science, University of Limerick, Limerick, Ireland.
Siobhan McCarthyAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Cian HurleySchool of Microbiology, University College Cork, Cork, Ireland.
Tarini Shankar GhoshAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Jakki C CooneyDepartment of Biological Science, University of Limerick, Limerick, Ireland.
Ann-Marie TobinDepartment of Dermatology, Tallaght University Hospital, Dublin, Ireland.
Michelle MurphyDepartment of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Eibhlís M O'ConnorDepartment of Biological Science, University of Limerick, Limerick, Ireland.
Fergus ShanahanAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Paul W O'TooleAPC Microbiome Ireland, University College Cork, Cork, Ireland.
APC Microbiome Institute · IEUniversity College Cork · IEUniversity of Limerick · IESouth Infirmary Victoria University Hospital · IETallaght University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The chronic inflammatory skin disease Hidradenitis suppurativa (HS) is strongly associated with Crohn's Disease (CD). HS and CD share clinical similarities and similar inflammatory pathways are upregulated in both conditions. Increased prevalence of inflammatory disease in industrialised nations has been linked to the Western diet. However, gut microbiota composition and diet interaction have not been compared in HS and CD. Methods: Here we compared the fecal microbiota (16S rRNA gene amplicon sequencing) and habitual diet of previously reported subjects with HS ( Results and discussion: Patients with HS consumed a Western diet similar to patients with CD. Meanwhile, habitual diet in HS and CD was significantly different to controls. Previously, we detected differences in microbiota composition among patients with HS from that of controls. We now show that 40% of patients with HS had a microbiota configuration similar to that of CD, characterised by the enrichment of pathogenic genera (Enterococcus, Veillonella and Escherichia_Shigella) and the depletion of putatively beneficial genera (Faecalibacterium). The remaining 60% of patients with HS harboured a normal microbiota similar to that of controls. Antibiotics, which are commonly used to treat HS, were identified as a co-varying with differences in microbiota composition. We examined the levels of several inflammatory markers highlighting that growth-arrest specific 6 (Gas6), which has anti-inflammatory potential, were significantly lower in the 40% of patients with HS who had a CD microbiota configuration. Levels of the pro-inflammatory cytokine IL-12, which is a modulator of intestinal inflammation in CD, were negatively correlated with the abundance of health-associated genera in patients with HS. In conclusion, the fecal microbiota may help identify patients with HS who are at greater risk for development of CD.

Indexed as

Crohn’s diseasedietgut microbiotaHidradenitis suppurativainflammation

Identifiers

PMID38029085
PMCPMC10667482
OpenAlexW4388633289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.